Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PG2 BEAM: PG2 for Chemotherapy-Induced Toxicity in Breast Cancer
NCT03314805Phase 2Completed
- Sponsor
- PhytoHealth Corporation
- Start
- Mar 2018
- Primary completion
- May 2021
- Modality
- PE (Plant Extract)
- Countries
- 1
01
Overview
A Phase 2 trial of astragalus polysaccharides in cancer-related fatigue (CRF), neutropenia, sponsored by PhytoHealth Corporation. Started Mar 2018; status: completed.
02
Drugs
astragalus polysaccharides
03
Conditions
cancer-related fatigue (CRF)neutropenia
Beyond the preview
Go deeper on NCT03314805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03314805.